Zimmer Biomet Holdings ZBH Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$292.8M-34.3% | -$218M-8.3% | -$201.2M-22.1% | -$164.8M+20.9% | ||
| $8.23B+7.2% | $7.68B+3.8% | $7.39B+6.5% | $6.94B+1.6% | ||
| $2.49B+13.8% | $2.19B+5.2% | $2.08B+3.2% | $2.02B+3.0% | ||
| $5.74B+4.6% | $5.49B+3.3% | $5.31B+7.9% | $4.92B+1.1% | ||
| 69.7%-1.8pp | 71.5%-0.4pp | 71.8%+0.9pp | 70.9%-0.4pp | ||
| $458.5M+4.8% | $437.4M-4.6% | $458.7M+13.0% | $406M-6.8% | ||
| $3.26B+11.2% | $2.93B+3.2% | $2.84B+2.8% | $2.76B-2.9% | ||
| $7.13B+11.6% | $6.39B+4.5% | $6.12B-2.0% | $6.24B+4.6% | ||
| $1.1B-14.6% | $1.29B+0.6% | $1.28B+76.3% | $724.6M-15.8% | ||
| 13.3%-3.4pp | 16.7%-0.5pp | 17.3%+6.8pp | 10.4%-2.2pp | ||
| $25.5M+182% | -$31.1M-234% | -$9.3M+92.7% | -$128M— | ||
| $830.8M-19.9% | $1.04B-2.9% | $1.07B— | —— | ||
| —— | $131.4M— | —— | $112.3M— | ||
| $3.55-20.0% | $4.44-9.0% | $4.88— | —— | ||
| $2.19B-3.9% | $2.28B+2.4% | $2.23B+35.0% | $1.65B-8.2% | ||
| 26.6%-3.1pp | 29.7%-0.4pp | 30.2%+6.4pp | 23.8%-2.5pp | ||
| $1.1B-14.6% | $1.29B+0.6% | $1.28B+76.3% | $724.6M-15.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Zimmer Biomet Holdings's revenue?
- Zimmer Biomet Holdings (ZBH) generated $8.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Zimmer Biomet Holdings profitable?
- Zimmer Biomet Holdings reported $761.1M in net income over the trailing twelve months, a 9.1% net margin.
- What are Zimmer Biomet Holdings's profit margins?
- Gross margin is 70.0% and operating margin is 14.0%, with a 9.1% net margin.
- What is Zimmer Biomet Holdings's earnings per share?
- Zimmer Biomet Holdings's diluted EPS over the trailing twelve months is $3.86.
- Where does Zimmer Biomet Holdings's income statement data come from?
- Every line is extracted from Zimmer Biomet Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
